Credit Suisse Starts Diplomat Pharmacy (DPLO) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Wells Fargo Starts Diplomat Pharmacy (DPLO) at Market Perform
November 19, 2014 8:50 AM ESTWells Fargo initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with a Market Perform rating and a price target of $24-$26.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreWilliam Blair Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 7:35 AM ESTWilliam Blair initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreJPMorgan Starts Diplomat Pharmacy (DPLO) at Overweight
November 19, 2014 7:29 AM ESTJPMorgan initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Overweight rating and a price target of $28.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreLeerink Swann Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 7:28 AM ESTLeerink Swann initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... More